The atypical antipsychotic clozapine has been reported to be associated with metabolic adverse effects, including type-2 diabetes mellitus. We present two cases of diabetes mellitus associated with clozapine treatment. One case resolved entirely upon withdrawal of the drug, whereas the other did not. We discuss the molecular basis of the diabetogenic action of clozapine and recommendations for monitoring.
Ardizzone T D , Bradley R J , Freeman A M , Dwyer D S (2001) Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine and structural analogues of clozapine . Brain Res923: 82-90
2.
Avram A M , Patel V , Taylor H C , Kirwan J P , Kalhan S (2001) Euglycaemic clamp study in clozapine-induced diabetic ketoacidosis . Ann Pharmacother35: 1381-1387
3.
Dwyer D S , Liu Y , Bradley R J (1999a) Dopamine receptor antagonists modulate glucose uptake in rat phaeochromocytoma (PC12) cells . Neurosci Lett274: 151-154
4.
Dwyer D S , Pinkofsky H B , Liu Y , Bradley R J (1999b) Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells . Prog Neuropsychopharmacol Biol Psychiatry23: 69-80
5.
Gould G W , Holman G D (1993) The glucose transporter family . Biochem J295: 329-341
6.
Henderson D C (2001) Clozapine: diabetes mellitus, weight gain and lipid abnormalities . J Clin Psychiatry62(Suppl 23): 39-44
7.
Koller E , Schneider B , Bennett K , Dubitsky G (2001) Clozapine-associated diabetes . Am J Med111: 716-723
8.
Koro C E , Fedder D O , L’Italien G J , Weiss S S , Magder L S , Kreyenbuhl J , Revicki D A , Buchanan R W (2002) Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case control study . Br Med J325: 243-245
9.
Leonard P , Halley A , Browne S (2002) Prevalenece of obesity, lipid and glucose abnormalities in outpatients prescribed clozapine . Irish Med J95: 119-120
10.
Lindenmayer J P , Nathan A M , Smith R C (2001) Hyperglycaemia associated with the use of atypical antipsychotics . J Clin Psychiatry174: 180-181
11.
Livingstone C , Dominiczak A F , Campbell I W , Gould G W (1995) Insulin resistance, hypertension and GLUT4 . Clin Sci89: 109-116
12.
Livingstone C , Rampes H (2003) Atypical antipsyhotic drugs and diabetes . Pract Diab Int20: 327-331
13.
Mohan D , Gorden H , Hindley N , Barker A (1999) Schizophrenia and diabetes mellitus . Br J Psychiatry174: 180-181
14.
Moller D E , Flier J S (1991) Insulin resistance - mechanisms, syndromes and implications . N Eng J Med325: 938-948
15.
Munro J , O’Sullivan D , Andrews C , Arana A , Mortimer A , Kerwin R (1999) Active monitoring of 12760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance . Br J Psychiatry175: 576-580
16.
Newcomer J W , Haupt D W , Fucetola R , Melson A K , Schweiger J A , Cooper B P , Selke G (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia . Arch Gen Psychiatry59: 337-345
17.
Ramankutty G (2002) Olanzapine-induced destabilisation of diabetes in the absence of weight gain . Acta Psychiatr Scand105: 235-236
18.
Taha C , Klip A (1999) The insulin signaling pathway . J Membr Biol169: 1-12
19.
Tsai S J , Huang Y H , Huang H J , Sim C B (2001) Reduced regional [14C]-2-deoxyglucose uptake in response to long term clozapine administration in rats . Neuropsychobiology44: 36-40
20.
Wirsching D A , Boyd J A , Meng L R , Ballon J S , Marder S R , Wirshing WC (2002) The effects of novel antipsychotics on glucose and lipid levels . J Clin Psychiatry63: 856-865
